Pax Group: Difference between revisions
imported>Elaeagnifolia No edit summary |
imported>Elaeagnifolia No edit summary |
||
| Line 1: | Line 1: | ||
The Pax Group is | The Pax Group is the world's largest multinational group that started with industrial beginnings, and who now hold enormous assets worldwide. It includes dominant positions in multiple sectors, including industrial manufacturing, finance, real estate, and other fields. | ||
In recent years, internal power shifts such as recent changes in management and the balance of power have drawn the public's attention | It operates both domestically and in a dozen countries abroad. In recent years, the Pax Group expanded its investments in its bio pharmaceuticaland gene-based medicine research and development has made great progress in the field, second only to [[Crimson Biotech]]. | ||
In 2026, [[Austin von Hagen]], the chairman of the board, announced his retirement and appointed his eldest son [[Giann von Hagen]] as the CEO. | |||
Now in 2029, internal power shifts such as recent changes in management and the balance of power due to changes in the company's direction have drawn the public's attention. Giann was re-assigned to a secret project while the second scion of the von Hagen Family - who was originally studying art abroad - was called back to Stellis to replace his elder brother as the Pax Group's CEO.<ref>https://twitter.com/TearsofThemisEN/status/1387043902339784708</ref> | |||
==Members of {{PAGENAME}}== | ==Members of {{PAGENAME}}== | ||
{{Organization member | |||
|name=Austin von Hagen | |||
|role=Retired Chairman of the Board | |||
}} | |||
{{Organization member | |||
|name=Giann von Hagen | |||
|role=CEO | |||
}} | |||
{{Organization member | {{Organization member | ||
|name=Marius von Hagen | |name=Marius von Hagen | ||
Revision as of 09:12, 8 May 2021
The Pax Group is the world's largest multinational group that started with industrial beginnings, and who now hold enormous assets worldwide. It includes dominant positions in multiple sectors, including industrial manufacturing, finance, real estate, and other fields.
It operates both domestically and in a dozen countries abroad. In recent years, the Pax Group expanded its investments in its bio pharmaceuticaland gene-based medicine research and development has made great progress in the field, second only to Crimson Biotech.
In 2026, Austin von Hagen, the chairman of the board, announced his retirement and appointed his eldest son Giann von Hagen as the CEO.
Now in 2029, internal power shifts such as recent changes in management and the balance of power due to changes in the company's direction have drawn the public's attention. Giann was re-assigned to a secret project while the second scion of the von Hagen Family - who was originally studying art abroad - was called back to Stellis to replace his elder brother as the Pax Group's CEO.[1]
Members of Pax Group
- Austin von Hagen - Retired Chairman of the Board
- Giann von Hagen - CEO
- Marius von Hagen - Heir
